Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 pharmacokinetic study of intravenous Mildronate injection in healthy Chinese men
ChiCTR-TNC-10000939Phase 4Completed
- Sponsor
- Changchun Xiangtong Pharmaceutical
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meldonium (2 arms), sponsored by Changchun Xiangtong Pharmaceutical. Primary endpoint: Concentration of Mildronate in human plasma and urine. Started Oct 2007; status: completed.
02
Drugs
meldonium
Beyond the preview
Go deeper on ChiCTR-TNC-10000939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-10000939.